#
Title
1

Asundexian for Secondary Stroke Prevention

2

Piperacillin–Tazobactam Tolerability in Patients with a Labeled Penicillin Allergy: The PIPPEN Trial

3

Clinical Impact of Fomepizole as an Adjunct Therapy in High-Risk Acetaminophen Overdose

4

A Comparison Between 8.4% Sodium Bicarbonate and 3% Hypertonic Saline in Severe Hyponatremia

5

Tenecteplase Prior to Endovascular Treatment for Ischemic Stroke at 4.5 to 24 Hrs:The TNK-PLUS Trial

6

Magnesium in Addition to Prochlorperazine for the Treatment of Migraines: The MIGraine-2 Trial

7

Research Recap: Evaluation of Olanzapine for Cannabinoid Hyperemesis Syndrome in the ED

8

Intramuscular Droperidol, Olanzapine, Midazolam, or Lorazepam for Meth Intoxication in the ED

9

Recombinant Factor VIIa vs Placebo for Spontaneous ICH Within 2 Hours of Onset: The FASTEST Trial

10

Navigating the Pharmacologic Terrain in Pseudo-Pulseless Electrical Activity

11

Succinylcholine vs Rocuronium for Pediatric Rapid Sequence Intubation in the Emergency Department

12

IV Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants​

13

Fewer Admissions, Shorter Stays: Phenobarbital Use for Alcohol Withdrawal in the ED

14

Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism: The COBRRA Trial

15

Emergency Department-Initiated Buprenorphine for Opioid Use Disorder

16

The HOPE Randomized Clinical Trial: Alteplase for Acute Ischemic Stroke at 4.5 to 24 Hours

17

Tranexamic Acid Timing and Mortality Impact After Trauma